Your browser doesn't support javascript.
loading
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.
Gentile, Massimo; Morabito, Fortunato; Del Poeta, Giovanni; Mauro, Francesca Romana; Reda, Gianluigi; Sportoletti, Paolo; Laurenti, Luca; Coscia, Marta; Herishanu, Yair; Recchia, Anna Grazia; Varettoni, Marzia; Murru, Roberta; Chiarenza, Annalisa; Condoluci, Adalgisa; Moia, Riccardo; Pietrasanta, Daniela; Loseto, Giacomo; Consoli, Ugo; Scortechini, Ilaria; Rossi, Francesca Maria; Zucchetto, Antonella; Fraticelli, Vincenzo; Vigna, Ernesto; Botta, Cirino; Tripepi, Giovanni; Arrigo, Graziella D'; Rago, Angela; Angeletti, Ilaria; Biagi, Annalisa; Del Giudice, Ilaria; Bomben, Riccardo; Rigolin, Gian Matteo; Rossi, Davide; Di Raimondo, Francesco; Gaidano, Gianluca; Polliack, Aaron; Cuneo, Antonio; Foà, Robin; Gattei, Valter.
Afiliação
  • Gentile M; Hematology Unit AO of Cosenza, Cosenza, Italy. massim.gentile@tiscali.it.
  • Morabito F; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy. massim.gentile@tiscali.it.
  • Del Poeta G; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Mauro FR; Hematology Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.
  • Reda G; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Sportoletti P; Division of Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Laurenti L; Division of Ematologia, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Coscia M; Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Herishanu Y; Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Italy.
  • Recchia AG; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Varettoni M; Sourasky Medical Center, Institute of Hematology, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Murru R; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Chiarenza A; Division of Haematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Condoluci A; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, Italy.
  • Moia R; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
  • Pietrasanta D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Loseto G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Consoli U; Division of Hematology, Azienda Ospedaliera SS Arrigo e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Scortechini I; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Rossi FM; Department of Hematology, G. Garibaldi Hospital, Catania, Italy.
  • Zucchetto A; Clinica di Ematologia Ospedali Riuniti, Ancona, Italy.
  • Fraticelli V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, (PN), Italy.
  • Vigna E; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, (PN), Italy.
  • Botta C; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Tripepi G; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Arrigo G; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Rago A; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Angeletti I; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Biagi A; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.
  • Del Giudice I; CNR-IFC, Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Bomben R; CNR-IFC, Research Unit of Reggio Calabria, Reggio Calabria, Italy.
  • Rigolin GM; UOSD Ematologia ASL Roma 1, Roma, Italy.
  • Rossi D; Reparto di Oncoematologia Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • Di Raimondo F; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Gaidano G; Division of Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Polliack A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, (PN), Italy.
  • Cuneo A; Hematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Foà R; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Gattei V; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
Leukemia ; 35(1): 235-238, 2021 01.
Article em En | MEDLINE | ID: mdl-32286543
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2021 Tipo de documento: Article